Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 25.10
-0.28 (-1.10%)
May 13, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 1.70 billion as of May 13, 2025. Its market cap has increased by 15.91% in one year.
Market Cap
1.70B
Enterprise Value
2.47B
Revenue
181.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.10
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 1.70B, an increase of 5,442.20%. That is a compound annual growth rate of 26.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 102.97B |
| Sectra AB | 59.23B |
| Getinge AB | 50.70B |
| Camurus AB | 39.14B |
| Medicover AB | 36.18B |
| AddLife AB | 22.95B |
| Vitrolife AB | 21.42B |
| Vimian Group AB | 20.64B |